STOCK TITAN

Maxeon Solar Technologies Announces Third Quarter 2022 Financial Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Maxeon Solar Technologies reported Q3 2022 results, achieving key milestones in its distributed generation and utility-scale businesses. Shipments increased to 605 MW, with revenue reaching $275.4 million, up from $238.1 million in Q2. The company anticipates achieving break-even gross margins in Q4 2022, driven by improved performance in Europe and a new partnership with Greentech Renewables. Looking ahead, Maxeon expects a shipment range of 680-720 MW in Q4, with projected revenues between $290-$330 million.

Positive
  • Revenue increased by 15.7% from Q2 to $275.4 million.
  • Achieved record volume in the distributed generation business in Europe.
  • Expecting break-even gross margins in Q4 2022.
Negative
  • Gross loss of $15.7 million in Q3 2022, even though it improved from $39.3 million in Q2.
  • Net loss attributable to stockholders was $44.7 million.

--Achieved Key Distributed Generation and Utility-Scale Milestones--
--US Manufacturing Initiative Approaching Key Site Selection and Financing Milestones--

SINGAPORE, Nov. 10, 2022 /PRNewswire/ -- Maxeon Solar Technologies, Ltd. (NASDAQ: MAXN) ("Maxeon" or "the Company"), a global leader in solar innovation and channels, today announced its financial results for the third quarter ended October 2, 2022.

Maxeon's Interim Chief Executive Officer Mark Babcock noted, "Maxeon delivered Q3 financial results consistent with guidance and achieved key strategic milestones in both our distributed generation (DG) and utility-scale businesses. In Europe, DG posted another record quarter for volume, revenue and beyond the panel product contributions. These factors drove improved financial results for the Company overall, and the business trajectory is expected to facilitate overall break-even gross margins in the fourth quarter. The DG business also executed on strategic expansion initiatives in the United States which are expected to help Maxeon achieve overall profitability next year. Specifically, we secured the first bookings with our new residential partner Greentech Renewables."

Commenting on the utility-scale business, Babcock added, "The North America Utility-Scale business continues to expand shipment volume with multiple daily deliveries from Mexico to our customers in the United States, and our Malaysian PERC cell fab has now ramped to over one gigawatt of capacity. We are confident that the completion of our full capacity ramp in 2023 and the transition to our higher ASP contracted backlog will meaningfully improve the profitability of this business."

Babcock continued, "Our teams are executing well and we are excited by the trajectory toward achievement of our Long-Term Financial Model within 2023. As our line of sight on this transformation becomes clearer, we are accelerating major growth initiatives for 2024 to 2026 topline growth and EBITDA expansion. In DG, we are expecting to ship our first storage units next quarter. In utility-scale, we're approaching key site selection and  DOE Loan Guarantee Program Office milestones for our proposed 3 gigawatt U.S. cell and module facility. In Summary, we believe we are in an excellent position to continue our growth trajectory beyond 2023.

Selected Q3 Unaudited Financial Summary

(In thousands, except shipments)

Fiscal Q3 2022


Fiscal Q2 2022


Fiscal Q3 2021

Shipments, in MW

605


521


566

Revenue

$                   275,449


$                   238,080


$                   220,488

Gross loss(1)

(15,747)


(39,324)


(16,708)

GAAP Operating expenses

41,196


35,701


32,639

GAAP Net loss attributable to the stockholders(1)

(44,691)


(87,920)


(65,363)

Capital expenditures

16,110


18,231


54,140








Other Financial Data(1), (2)

(In thousands)

Fiscal Q3 2022


Fiscal Q2 2022


Fiscal Q3 2021

Non-GAAP Gross loss

$                   (15,492)


$                   (23,905)


$                   (16,353)

Non-GAAP Operating expenses

34,651


30,162


29,678

Adjusted EBITDA(3)

(34,501)


(36,833)


(36,991)



(1)   

The Company's GAAP and Non-GAAP results were impacted by the effects of certain items. Refer to "Supplementary information affecting GAAP and Non-GAAP results" below.



(2)   

The Company's use of Non-GAAP financial information, including a reconciliation to U.S. GAAP, is provided under "Use of Non-GAAP Financial Measures" below.



(3)  

The Adjusted EBITDA for three months ended October 3, 2021 did not contain an adjustment for equity in losses of unconsolidated investees and related gain on such equity investment. For a reconciliation of Adjusted EBITDA to GAAP Net Loss for the three months ended October 3, 2021, please refer to our Forms 6-K furnished with the SEC on November 17, 2021.

 

Supplementary information affecting GAAP and Non-GAAP results



Three Months Ended

(In thousands)

Financial
statements item
affected

October 2, 2022


July 3, 2022


October 3, 2021

Incremental cost of above market
polysilicon(1)

Cost of revenue

603


3,308


11,490

Loss on ancillary sales of excess
polysilicon(2)

Cost of revenue



7,425



(1)  

Relates to the difference between our contractual cost for the polysilicon under the long-term fixed supply agreements with our supplier which is ending in January 2023 and the price of polysilicon available in the market as derived from publicly available information at the beginning of each quarter, multiplied by the volume of modules sold within the quarter.



(2)  

In order to reduce inventory and improve working capital, we have periodically elected to sell polysilicon inventory procured under the long-term fixed supply agreements in the market at prices below our purchase price, thereby incurring a loss. As the sales were committed during the three months ended April 4, 2022, the loss on firm purchase commitment in connection to the ancillary sales to be delivered in subsequent quarters was provided then.



Fourth Quarter 2022 Outlook

For the fourth quarter of 2022, the Company anticipates the following results:

(In millions, except shipments)

 Outlook

Shipments, in MW

680 - 720 MW

Revenue

$290 - $330

Gross (loss) profit(1)

$(1) - $9

Non-GAAP gross profit(1), (2)

$0 - $10

Operating expenses

$41 ± $2

Non-GAAP operating expenses(3)

$36± $2

Adjusted EBITDA(1), (4)

$(17) - $(27)

Capital expenditures(5)

$16 - $20

Out-of-market polysilicon cost(1)

$1



(1)  

Outlook for Gross (loss) profit, Non-GAAP gross profit and Adjusted EBITDA includes out-of-market polysilicon cost.



(2)  

The Company's Non-GAAP gross profit is impacted by the effects of adjusting for stock-based compensation expense.



(3)  

The Company's Non-GAAP operating expenses are impacted by the effects of adjusting for stock-based compensation expense and restructuring charges and fees.



(4)  

The Company cannot provide a reconciliation between its Adjusted EBITDA projection and the most directly comparable GAAP measures without unreasonable efforts because it is unable to predict with reasonable certainty the ultimate outcome of the remeasurement gain or loss of the prepaid forward and the equity in gain or loss of unconsolidated investees.



(5)  

Capital expenditures are directed mainly to upgrading production to Maxeon 6 in our Malaysia factory, the purchase of cell and module equipment for our 1.8 GW of Performance line capacity for the U.S., as well as developing Maxeon 7 technology and operating a pilot line.  We are evaluating our Maxeon 7 capacity growth plan, and because of that our previous capex indication for retrofitting Maxeon 3 production lines is no longer relevant.



These anticipated results for the fourth quarter of 2022 are preliminary, unaudited and represent the most current information available to management. The Company's business outlook is based on management's current views and estimates with respect to market conditions, production capacity, the uncertainty of the continuing impact of the COVID-19 pandemic, and the global economic environment. Please refer to Forward Looking Statements section below. Management's views and estimates are subject to change without notice.

For more information

Maxeon's third quarter 2022 financial results and management commentary can be found on Form 6-K by accessing the Financials & Filings page of the Investor Relations section of Maxeon's website at: https://corp.maxeon.com/investor-relations. The Form 6-K and Company's other filings are also available online from the Securities and Exchange Commission at www.sec.gov.

Conference Call Details

The Company will hold a conference call on November 10, 2022, at 5:00 PM U.S. ET / November 11, 2022, at 6:00 AM Singapore Time, to discuss results and to provide an update on the business.

To join the live conference call, participants must first register here, where a dial-in number will be provided.

A simultaneous webcast of the conference call will be available on Maxeon's website at https://corp.maxeon.com/events-and-presentations. A webcast replay will be available on Maxeon's website for one year at https://corp.maxeon.com/events-and-presentations.

About Maxeon Solar Technologies

Maxeon Solar Technologies Ltd (NASDAQ: MAXN) is Powering Positive Change™. Headquartered in Singapore, Maxeon designs and manufactures Maxeon® and SunPower® brand solar panels, and has sales operations in more than 100 countries, operating under the SunPower brand in certain countries outside the United States. The Company is a leader in solar innovation with access to over 1,000 patents and two best-in-class solar panel product lines. Maxeon products span the global rooftop and solar power plant markets through a network of more than 1,700 trusted partners and distributors. A pioneer in sustainable solar manufacturing, Maxeon leverages a +35-year history in the solar industry and numerous awards for its technology. For more information about how Maxeon is Powering Positive Change™ visit us at https://www.maxeon.com/, on LinkedIn and on Twitter @maxeonsolar.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, but not limited to, statements regarding: (a) our expectations regarding pricing trends, demand and growth projections; (b) potential disruptions to our operations and supply chain that may result from epidemics, natural disasters or military conflicts, including the duration, scope and impact on the demand for our products, market disruptions from the war in Ukraine and the pace of recovery from the COVID-19 pandemic; (c) anticipated product launch timing and our expectations regarding ramp, customer acceptance and demand, upsell and expansion opportunities; (d) our expectations and plans for short- and long-term strategy, including our anticipated areas of focus and investment, market expansion, product and technology focus, and projected growth and profitability; (e) our ability to meet short term and long term material cash requirements including our obligations under the long-term polysilicon supply agreement, our ability to complete an equity or debt offering or financing at favorable terms, if at all, and our overall liquidity, substantial indebtedness and ability to obtain additional financing; (f) our technology outlook, including anticipated fab utilization and expected ramp and production timelines for the Company's Maxeon 5 and 6, next-generation Maxeon 7 and Performance line solar panels, expected cost reductions, and future performance; (g) our strategic goals and plans, including partnership discussions with respect to the Company's next-generation technology, and our relationships with existing customers, suppliers and partners, and our ability to achieve and maintain them; (h) our expectations regarding our future performance and revenues resulting from contracted orders, bookings, backlog, and pipelines in our sales channels; (i) our fourth quarter fiscal year 2022 guidance, including shipments, revenue, gross profit, non-GAAP gross profit, operating expenses, non-GAAP operating expenses, Adjusted EBITDA, capital expenditures, out-of-market polysilicon cost, and related assumptions; and (j) our projected effective tax rate and changes to the valuation allowance related to our deferred tax assets.

The forward-looking statements can be also identified by terminology such as "may," "might," "could," "will," "aims," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the quotations from management in this press release and Maxeon's operations and business outlook contain forward-looking statements.

These forward-looking statements are based on our current assumptions, expectations and beliefs and involve substantial risks and uncertainties that may cause results, performance or achievement to materially differ from those expressed or implied by these forward-looking statements. These statements are not guarantees of future performance and are subject to a number of risks. The reader should not place undue reliance on these forward-looking statements, as there can be no assurances that the plans, initiatives or expectations upon which they are based will occur. Factors that could cause or contribute to such differences include, but are not limited to: (1) challenges in executing transactions key to our strategic plans, including regulatory and other challenges that may arise; (2) our liquidity, substantial indebtedness, terms and conditions upon which our indebtedness is incurred and ability to obtain additional financing for our projects, customers and operations; (3) our ability to manage supply chain cost increases and operating expenses; (4) potential disruptions to our operations and supply chain that may result from damage or destruction of facilities operated by our suppliers, difficulties in hiring or retaining key personnel, epidemics, natural disasters, including impacts of the COVID-19 pandemic, or the war in Ukraine; (5) our ability to manage our key customers and suppliers; (6) the success of our ongoing research and development efforts and our ability to commercialize new products and services, including products and services developed through strategic partnerships; (7) competition in the solar and general energy industry and downward pressure on selling prices and wholesale energy pricing, including impacts of inflation, economic recession  and foreign exchange rates upon customer demand; (8) changes in regulation and public policy, including the imposition and applicability of tariffs; (9) our ability to comply with various tax holiday requirements as well as regulatory changes or findings affecting the availability of economic incentives promoting use of solar energy and availability of tax incentives or imposition of tax duties; (10) fluctuations in our operating results and in the foreign currencies in which we operate; (11) appropriately sizing, or delays in expanding, our manufacturing capacity and containing manufacturing and logistics difficulties that could arise; (12) unanticipated impact to customer demand and sales schedules due, among other factors, to the spread of COVID-19, the war in Ukraine, economic recession and environmental disasters; (13) challenges managing our acquisitions, joint ventures and partnerships, including our ability to successfully manage acquired assets and supplier relationships; (14) reaction by securities or industry analysts to our quarterly guidance which, in combination with our results of operations, may cause them to cease publishing research or reports about us, or adversely change their recommendations regarding our ordinary shares, which may negatively impact the market price of our ordinary shares and volume of our stock trading; and (15) unpredictable outcomes resulting from our litigation activities or other disputes. A detailed discussion of these factors and other risks that affect our business is included in filings we make with the Securities and Exchange Commission ("SEC") from time to time, including our most recent report on Form 20-F, particularly under the heading "Risk Factors". Copies of these filings are available online from the SEC at www.sec.gov, or on the SEC Filings section of our Investor Relations website at https://corp.maxeon.com/investor-relations. All forward-looking statements in this press release are based on information currently available to us, and we assume no obligation to update these forward-looking statements in light of new information or future events.

Use of Non-GAAP Financial Measures

We present certain non-GAAP measures such as non-GAAP gross loss, non-GAAP operating expenses and earnings before interest, taxes, depreciation and amortization ("EBITDA") adjusted for stock-based compensation, restructuring charges and fees, remeasurement loss on prepaid forward and physical delivery forward, loss on extinguishment of debt, impairment and equity in losses of unconsolidated investees ("Adjusted EBITDA") to supplement our consolidated financial results presented in accordance with GAAP. Non-GAAP gross loss is defined as gross loss excluding stock-based compensation. Non-GAAP operating expenses is defined as operating expenses excluding stock-based compensation and restructuring charges and fees.

We believe that non-GAAP gross loss, non-GAAP operating expenses and Adjusted EBITDA provide greater transparency into management's view and assessment of the Company's ongoing operating performance by removing items management believes are not representative of our continuing operations and may distort our longer-term operating trends. We believe these measures are useful to help enhance the comparability of our results of operations across different reporting periods on a consistent basis and with our competitors, distinct from items that are infrequent or not associated with the Company's core operations as presented above. We also use these non-GAAP measures internally to assess our business, financial performance and current and historical results, as well as for strategic decision-making and forecasting future results. Given our use of non-GAAP measures, we believe that these measures may be important to investors in understanding our operating results as seen through the eyes of management. These non-GAAP measures are neither prepared in accordance with GAAP nor are they intended to be a replacement for GAAP financial data, should be reviewed together with GAAP measures and may be different from non-GAAP measures used by other companies.

As presented in the "Reconciliation of Non-GAAP Financial Measures" section, each of the non-GAAP financial measures excludes one or more of the following items in arriving to the non-GAAP measures:

  • Stock-based compensation expense. Stock-based compensation relates primarily to equity incentive awards. Stock-based compensation is a non-cash expense that is dependent on market forces that are difficult to predict and is excluded from non-GAAP gross loss, non-GAAP operating expense and Adjusted EBITDA. Management believes that this adjustment for stock-based compensation expense provides investors with a basis to measure our core performance, including the ability to compare our performance with the performance of other companies, without the period-to-period variability created by stock-based compensation.

  • Restructuring charges and fees. We incur restructuring charges and fees related to reorganization plans aimed towards realigning resources consistent with our global strategy and improving its overall operating efficiency and cost structure. Restructuring charges and fees are excluded from non-GAAP operating expenses and Adjusted EBITDA because they are not considered core operating activities. Although we have engaged in restructuring activities and initiatives, past activities have been discrete events based on unique sets of business objectives. As such, management believes that it is appropriate to exclude restructuring charges and fees from our non-GAAP financial measures as they are not reflective of ongoing operating results nor do these charges contribute to a meaningful evaluation of our past operating performance.

  • Remeasurement loss on prepaid forward and physical delivery forward. This relates to the mark-to-market fair value remeasurement of privately negotiated prepaid forward and physical delivery transactions. The transactions were entered into in connection with the issuance on July 17, 2020 of the 6.50% Green Convertible Senior Notes due 2025 for an aggregate principal amount of $200 million. The prepaid forward is remeasured to fair value at the end of each reporting period, with changes in fair value booked in earnings. The fair value of the prepaid forward is primarily affected by the Company's share price. The physical delivery forward was remeasured to fair value at the end of the Note Valuation Period on September 29, 2020, and was reclassified to equity after remeasurement, and will not be subsequently remeasured. The fair value of the physical delivery forward was primarily affected by the Company's share price. The remeasurement loss on prepaid forward and physical delivery forward is excluded from Adjusted EBITDA because it is not considered core operating activities. As such, management believes that it is appropriate to exclude the mark-to-market adjustments from our Adjusted EBITDA as it is not reflective of ongoing operating results nor do the loss contribute to a meaningful evaluation of our past operating performance.

  • Equity in losses (income) of unconsolidated investees and related gains. This relates to the loss (income) on our unconsolidated equity investment Huansheng JV and gains on such investment. This is excluded from our Adjusted EBITDA financial measure as it is non-cash in nature and not reflective of our core operational performance. As such, management believes that it is appropriate to exclude such charges as they do not contribute to a meaningful evaluation of our performance.

  • Loss related to settlement of price escalation dispute. This relates to loss arising from the settlement of price escalation dispute with a polysilicon supplier related to our long-term, firm commitment polysilicon supply agreement. This is excluded from our Adjusted EBITDA financial measure as it is non-recurring and not reflective of ongoing operating results. As such, management believes that it is appropriate to exclude such charges as the loss does not contribute to a meaningful evaluation of our past operating performance.

 

Reconciliation of Non-GAAP Financial Measures



Three Months Ended

(In thousands)

October 2, 2022


July 3, 2022


October 3, 2021

Gross loss

$                   (15,747)


$                   (39,324)


$                   (16,708)

Stock-based compensation

255


249


355

Loss related to settlement of price escalation dispute


15,170


Non-GAAP Gross loss

(15,492)


(23,905)


(16,353)







GAAP Operating expenses

41,196


35,701


32,639

Stock-based compensation

(5,918)


(1,896)


(1,447)

Restructuring charges and fees

(627)


(3,643)


(1,514)

Non-GAAP Operating expenses

34,651


30,162


29,678







GAAP Net loss attributable to the stockholders

(44,691)


(87,920)


(65,363)

Interest expense, net

8,035


5,685


6,671

Provision for income taxes

2,399


937


174

Depreciation

13,845


15,305


10,999

Amortization

50


75


68

EBITDA

(20,362)


(65,918)


(47,451)

Stock-based compensation

6,173


2,145


1,802

Loss related to settlement of price escalation dispute


15,170


Restructuring charges and fees

627


3,643


1,514

Remeasurement (gain) loss on prepaid forward

(24,521)


3,986


5,961

Equity in losses (income) of unconsolidated investees and related
gain

3,582


4,141


(3,892)

Loss on extinguishment of debt(2)



5,075

Adjusted EBITDA(1)

(34,501)


(36,833)


(36,991)



(1)

The Adjusted EBITDA for three months ended October 3, 2021 did not contain an adjustment for equity in losses of unconsolidated investees
and related gain on such equity investment. For a reconciliation of Adjusted EBITDA to GAAP Net Loss for the three months ended October 3,
2021, please refer to our Forms 6-K furnished with the SEC on November 17, 2021.



(2)

The loss on extinguishment of debt relates to the loss that arose from the termination of our $50.0 million working capital facility in September
2021 and the expiration of the availability period for draw down of our $75.0 million term loans in August 2021. This is excluded from Adjusted
EBITDA because it is not considered part of core operating activities given that such activities are discrete events based on unique sets of
business objectives.

 

Reconciliation of Non-GAAP Outlook


(In millions)

Outlook

Gross (loss) profit

$(1) - $9

Stock-based compensation

1

Non-GAAP gross profit

$0 - $10



Operating expenses

$41 ± $2

Stock-based compensation

(4)

Restructuring charges and fees

(1)

Non-GAAP operating expenses

$36± $2


©2022 Maxeon Solar Technologies, Ltd. All rights reserved. MAXEON is a registered trademark of Maxeon Solar Technologies, Ltd. Visit https://corp.maxeon.com/trademarks for more information.

 

MAXEON SOLAR TECHNOLOGIES, LTD.

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited)

(In thousands, except for shares data)



As of


October 2, 2022


January 2, 2022

Assets




Current assets:




Cash and cash equivalents

$                199,085


$                 166,542

Short-term securities

76,000


Restricted short-term marketable securities

915


1,079

Accounts receivable, net

58,481


39,730

Inventories

300,850


212,820

Advances to suppliers, current portion

13,869


51,045

Prepaid expenses and other current assets

119,794


61,904

Total current assets

$                768,994


$                 533,120

Property, plant and equipment, net

385,750


386,630

Operating lease right of use assets

18,071


15,397

Other intangible assets, net

247


420

Advances to suppliers, net of current portion


716

Deferred tax assets

8,784


5,183

Other long-term assets

74,667


115,077

Total assets

$             1,256,513


$              1,056,543

Liabilities and Equity




Current liabilities:




Accounts payable

$                293,279


$                 270,475

Accrued liabilities

89,103


78,680

Contract liabilities, current portion

132,745


44,059

Short-term debt

50,675


25,355

Operating lease liabilities, current portion

3,285


2,467

Total current liabilities

$                569,087


$                 421,036

Long-term debt

1,750


213

Contract liabilities, net of current portion

98,913


58,994

Operating lease liabilities, net of current portion

15,083


13,464

Convertible debt

376,927


145,772

Deferred tax liabilities

7,292


1,150

Other long-term liabilities

56,983


61,039

Total liabilities

$             1,126,035


$                 701,668

Commitments and contingencies




Equity:




Common stock, no par value (44,996,615 and 44,246,603 issued and outstanding as of
October 2, 2022 and January 2, 2022, respectively)

$                          —


$                           —

Additional paid-in capital

581,398


624,261

Accumulated deficit

(444,562)


(262,961)

Accumulated other comprehensive loss

(11,996)


(11,844)

Equity attributable to the Company

124,840


349,456

Noncontrolling interests

5,638


5,419

Total equity

130,478


354,875

Total liabilities and equity

$             1,256,513


$              1,056,543

 

MAXEON SOLAR TECHNOLOGIES, LTD.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

(In thousands, except per share data)



Three Months Ended


Nine Months Ended


October 2, 2022


October 3, 2021


October 2, 2022


October 3, 2021

Revenue

$                  275,449


$                  220,488


$                  736,610


$                  561,800

Cost of revenue

291,196


237,196


804,645


580,269

Gross loss

(15,747)


(16,708)


(68,035)


(18,469)

Operating expenses:








Research and development

11,968


12,632


38,278


35,827

Sales, general and administrative

29,143


18,493


74,414


64,554

Restructuring charges

85


1,514


1,615


7,534

Total operating expenses

41,196


32,639


114,307


107,915

Operating loss

(56,943)


(49,347)


(182,342)


(126,384)

Other income (expense), net








Interest expense, net

(8,035)


(6,671)


(18,505)


(21,337)

Loss on extinguishment of debt


(5,075)



(5,075)

Other, net

26,481


(5,663)


24,352


(23,119)

Other income (expense), net

18,446


(17,409)


5,847


(49,531)

Loss before income taxes and equity in losses
of unconsolidated investees

(38,497)


(66,756)


(176,495)


(175,915)

Provision for income taxes

(2,399)


(174)


(4,161)


(1,219)

Equity in (losses) income of unconsolidated
investees

(3,582)


917


(10,784)


(5,018)

Net loss

(44,478)


(66,013)


(191,440)


(182,152)

Net (income) loss attributable to
noncontrolling interests

(213)


650


(283)


964

Net loss attributable to the stockholders

$                  (44,691)


$                  (65,363)


$                (191,723)


$                (181,188)









Net loss per share attributable to stockholders:








Basic

$                      (1.09)


$                      (1.62)


$                      (4.70)


$                      (4.97)

Diluted

(1.09)


(1.62)


(4.70)


(4.97)









Weighted average shares used to compute net
loss per share:








Basic

40,951


40,420


40,818


36,462

Diluted

40,951


40,420


40,818


36,462

 

MAXEON SOLAR TECHNOLOGIES, LTD.

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(unaudited)

(In thousands)


Shares


Amount


Additional
Paid In
Capital


Accumulated
Deficit


Accumulated
Other
Comprehensive
Loss


Equity
Attributable
to the
Company


Noncontrolling

Interests


Total Equity

Balance at January 2, 2022

44,247


$         —


$         624,261


$       (262,961)


$           (11,844)


$         349,456


$               5,419


$         354,875

Effect of adoption of ASU 2020-06



(52,189)


10,122



(42,067)



(42,067)

Net loss




(59,112)



(59,112)


(85)


(59,197)

Issuance of common stock for stock-based
compensation, net of tax withheld

354



(2)




(2)



(2)

Distribution to noncontrolling interest







(64)


(64)

Recognition of stock-based compensation



1,466




1,466



1,466

Other comprehensive income





(803)


(803)



(803)

Balance at April 3, 2022

44,601


$         —


$         573,536


$       (311,951)


$           (12,647)


$         248,938


$               5,270


$         254,208

Net (loss) income


$         —


$                  —


$         (87,920)


$                    —


$         (87,920)


$                  155


$         (87,765)

Issuance of common stock for stock-based
compensation, net of tax withheld

108



(21)




(21)



(21)

Recognition of stock-based compensation



2,844




2,844



2,844

Other comprehensive income





(755)


(755)



(755)

Balance at July 3, 2022

44,709



576,359


(399,871)


(13,402)


163,086


5,425


168,511

Net (loss) income




(44,691)



(44,691)


213


(44,478)

Issuance of common stock for stock-based
compensation, net of tax withheld

288




(233)




(233)



(233)

Recognition of stock-based compensation



5,272




5,272



5,272

Other comprehensive income





1,406


1,406



1,406

Balance at October 2, 2022

44,997



581,398


(444,562)


(11,996)


124,840


5,638


130,478


















Shares


Amount


Additional
Paid In
Capital


Accumulated
Deficit


Accumulated
Other
Comprehensive
Loss


Equity
Attributable
to the
Company


Noncontrolling
Interests


Total Equity

Balance at January 3, 2021

33,995


$         —


$         451,474


$           (8,441)


$           (10,391)


$         432,642


$               6,645


$         439,287

Net loss




(38,814)



(38,814)


98


(38,716)

Issuance of common stock for stock-based
compensation, net of tax withheld

229



(2,550)




(2,550)



(2,550)

Recognition of stock-based compensation



1,570




1,570



1,570

Other comprehensive income





(79)


(79)



(79)

Balance at April 4, 2021

34,224


$         —


$         450,494


$         (47,255)


$           (10,470)


$         392,769


$               6,743


$         399,512

Net loss




(77,011)



(77,011)


(412)


(77,423)

Issuance of common stock, net of issuance cost

9,916



169,684




169,684



169,684

Issuance of common stock for stock-based
compensation, net of tax withheld

57



(1,262)




(1,262)



(1,262)

Recognition of stock-based compensation



2,097




2,097



2,097

Other comprehensive income





(473)


(473)



(473)

Balance at July 4, 2021

44,197



621,013


(124,266)


(10,943)


485,804


6,331


492,135

Net loss




(65,363)



(65,363)


(650)


(66,013)

Issuance of common stock for stock-based
compensation, net of tax withheld

35



(263)




(263)



(263)

Recognition of stock-based compensation



1,819




1,819



1,819

Other comprehensive income





185


185



185

Balance at October 3, 2021

44,232



622,569


(189,629)


(10,758)


422,182


5,681


427,863

















 

MAXEON SOLAR TECHNOLOGIES, LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

(In thousands)


Nine Months Ended


October 2, 2022


October 3, 2021

Cash flows from operating activities




Net loss

$             (191,440)


$                (182,152)

Adjustments to reconcile net loss to operating cash flows




Depreciation and amortization

42,263


30,095

Stock-based compensation

11,015


5,197

Non-cash interest expense

4,735


10,518

Equity in losses of unconsolidated investees

10,784


5,018

Gain from dilution of interest in joint venture


(2,975)

Deferred income taxes

2,540


1,926

Loss on disposal of property, plant and equipment

260


2,216

Loss on debt extinguishment


5,075

Remeasurement (gain) loss on prepaid forward

(20,137)


24,641

Gain on liquidation of subsidiaries

(235)


Other, net

886


(1,728)

Changes in operating assets and liabilities




Accounts receivable

(20,150)


18,378

Contract assets

1,016


172

Inventories

(87,984)


(50,884)

Prepaid expenses and other assets

(23,923)


(13,748)

Operating lease right-of-use assets

2,104


1,812

Advances to suppliers

37,892


31,304

Accounts payable and other accrued liabilities

68,609


52,922

Contract liabilities

127,814


35,914

Operating lease liabilities

(2,341)


(2,175)

Net cash used in operating activities

(36,292)


(28,474)

Cash flows from investing activities




Purchases of property, plant and equipment

(56,023)


(116,801)

Purchases of intangible assets

(41)


Purchase of short-term securities

(76,000)


Proceeds from disposal of short-term investments


1,318

Proceeds from (cash paid for) disposal of property, plant and
equipment

33


(283)

Net cash used in investing activities

(132,031)


(115,766)

Cash flows from financing activities




Proceeds from debt

196,388


130,265

Repayment of debt

(171,141)


(157,812)

Repayment of finance lease obligations

(433)


(535)

Payment for tax withholding obligations for issuance of common
stock upon vesting of restricted stock units

(257)


(4,075)

Net proceeds from issuance of convertible debt

188,812


Net proceeds from issuance of common stock


169,684

Distribution to noncontrolling interest

(64)


Net cash provided by financing activities

213,305


137,527

Effect of exchange rate changes on cash, cash equivalents and
restricted cash

348


67

Net increase (decrease) in cash, cash equivalents and restricted cash

45,330


(6,646)

Cash, cash equivalents and restricted cash, beginning of period

192,232


209,572

Cash, cash equivalents and restricted cash, end of period

$                237,562


$                   202,926

Non-cash transactions




Property, plant and equipment purchases funded by liabilities

$                   40,154


$                     36,724

Cost from issuance of common stock paid in shares


1,078

Property, plant and equipment obtained through capital lease

2,127


Right-of-use assets obtained in exchange for lease obligations

4,778


5,020


The following table reconciles our cash and cash equivalents and restricted cash reported on our Condensed Consolidated Balance Sheets and the cash, cash equivalents and restricted cash reported on our Condensed Consolidated Statements of Cash Flows as of October 2, 2022 and October 3, 2021:


(In thousands)

October 2, 2022


October 3, 2021

Cash and cash equivalents

$                  199,085


$                    174,940

Restricted cash, current portion, included in Prepaid expenses and
other current assets

35,968


3,962

Restricted cash, net of current portion, included in Other long-term
assets

2,509


24,024

Total cash, cash equivalents and restricted cash shown in Condensed
Consolidated Statements of Cash Flows

$                  237,562


$                    202,926

 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/maxeon-solar-technologies-announces-third-quarter-2022-financial-results-301674835.html

SOURCE Maxeon Solar Technologies, Ltd.

FAQ

What were Maxeon's financial results for Q3 2022?

Maxeon reported revenue of $275.4 million and shipments of 605 MW for Q3 2022.

What is Maxeon's revenue outlook for Q4 2022?

Maxeon anticipates revenues between $290 million and $330 million for Q4 2022.

How did Maxeon's distributed generation business perform in Q3 2022?

The distributed generation business achieved record volume and revenue in Q3 2022.

What is the expected gross margin for Maxeon in Q4 2022?

Maxeon expects to achieve break-even gross margins in Q4 2022.

What were the key milestones achieved by Maxeon in Q3 2022?

Maxeon achieved key milestones in its distributed generation and utility-scale businesses, including a new partnership with Greentech Renewables.

Maxeon Solar Technologies, Ltd. Ordinary Shares

NASDAQ:MAXN

MAXN Rankings

MAXN Latest News

MAXN Stock Data

116.81M
6.67M
71.27%
5.25%
9.12%
Solar
Technology
Link
United States of America
Singapore